NanoViricides, Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was USD 8.59 million compared to USD 8.11 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.7 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | -0.90% | 0.00% | +7.84% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.84% | 12.96M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NNVC Stock
- News NanoViricides, Inc.
- NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023